News

Clinical Trials Arena11m

BlossomHill doses first patient in SOLARA study’s expansion cohorts

BlossomHill Therapeutics has dosed the first subject in the expansion cohorts of the SOLARA Phase I/II trial to evaluate ...
Clinical Trials Arena2h

Lighthouse secures $49.2m NIA grant for Alzheimer’s therapy trial

Lighthouse secured a grant of $49.2m from the National Institute on Aging (NIA) to facilitate study of LHP588 for Alzheimer's ...
Clinical Trials Arena20h

Uncertainty remains over FDA block on China engineering of US cells

The FDA has announced it will no longer accept clinical trials that involve sending US patients cells from US to China for ...